Wera Kit
Product Images NDC 16714-370

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Wera (NDC 16714-370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Chemical structures of the active ingredients norethindrone and ethinyl estradiol as shown in the image. The structures depict the molecular layout of these hormone components found in the drug Wera.*

FDA Label Image

Image 02

A bar chart illustrating circulatory disease mortality rates per 100,000 woman-years. It compares mortality rates by age groups (15-24, 25-34, 35-44, 45+), smoking status, and oral contraceptive use with four categories: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers). Mortality rates increase with age, particularly for smokers who are ever-users of oral contraceptives.*

FDA Label Image

Image 03

Warning text panel for Wera oral contraceptive kit highlighting cardiovascular risks associated with smoking if over 35 years old. It emphasizes increased risk of heart attack, blood clots, and stroke linked to smoking combined with oral contraceptive use.*

FDA Label Image

Image 04

Wera kit blister card containing 28 oral tablets of norethindrone and ethinyl estradiol by Northstar Rx LLC. The card is arranged in four weekly rows, with light peach-colored tablets for weeks 1-3 and white tablets for week 4. Days of the week are labeled above each tablet. The card includes instructions and a reminder for monthly self breast exams.*

FDA Label Image

Image 05

An instructional illustration showing a hand holding a Wera kit blister pack of oral tablets. The diagram includes a day label strip indicating days of the week (MON to SUN) to align with the pill pack, with colored tablets organized by weeks (light peach and white). It demonstrates how to peel and place the day label on the blister pack for correct day tracking.*

FDA Label Image

Image 06

A warning text panel for Wera oral contraceptive kit, cautioning against use by smokers over age 35 due to increased risk of serious cardiovascular side effects such as heart attack, blood clots, or stroke. The text emphasizes increased risk with age and cigarette consumption.*

FDA Label Image

Image 07

Wera norethindrone and ethinyl estradiol oral kit blister card showing 28 tablets arranged in a weekly cycle with color-coded (light peach and white) round tablets. The card includes weekday labels from Sunday to Saturday, week numbers, and instructions to start and follow tablet colors accordingly. Labeler Northstar Rx LLC is noted on the card.*

FDA Label Image

Image 08

Illustration showing a hand placing a day-of-the-week label (MON through SUN) on a Wera oral contraceptive kit blister pack containing two rows of circular tablets. The diagram indicates the color coding for the tablets: light peach for the first three weeks and white for the fourth week. The image guides users to select and place the correct day label on the blister pack to help track daily dosage.*

FDA Label Image

Image 09

FDA Label Image

Image 10

Packaging label for Wera kit containing norethindrone and ethinyl estradiol tablets, USP at a strength of 0.5 mg / 0.035 mg. The label indicates a 28-day regimen with blister packs of tablets. It includes the NDC 16714-370-03 and states the product is Rx only. The labeler is Northstar Rx LLC. A blue flower image appears on multiple panels of the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.